TriangleNCT00002558 · OUTCOME
Overall Objective Response
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- 2 years
What was measured
Overall Objective Response will be assessed prior to dose-intensive therapy and at the completion of therapy. Complete disappearance of all clinical, radiographic and biochemical (normal AFP and HCG) evidence of disease for a minimum of 4 weeks (CR to chemotherapy). Patients must be free of disease for a minimum of 4 weeks. Partial Response: Complete disappearance of all biochemical evidence of disease in patients without a surgical procedure for a residual radiographic mass. Patients must demonstrate no biochemical recurrence or progression of radiographic masses for a minimum of four weeks (PR to chemotherapy}
Groups in this outcome
Group A
Group A: Prior Treatment Limited to \<= 6 Cycles of Cisplatin
Group B
Group B: Prior Treatment Limited to \> 6 Cycles of Cisplatin
| Group | Source count |
|---|---|
| Group A | 91 |
| Group B | 15 |
Reported measurements
Complete Response (CR)
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Group A | 50 | Not reported | Not reported | Not reported | Not reported |
| Group B | 4 | Not reported | Not reported | Not reported | Not reported |
Incomplete Response (IR)
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Group A | 36 | Not reported | Not reported | Not reported | Not reported |
| Group B | 8 | Not reported | Not reported | Not reported | Not reported |
Partial Response (PR)
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Group A | 5 | Not reported | Not reported | Not reported | Not reported |
| Group B | 3 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 50
- group Id
- OG001
- value
- 4
- title
- Complete Response (CR)
- categories
- measurements
- group Id
- OG000
- value
- 36
- group Id
- OG001
- value
- 8
- title
- Incomplete Response (IR)
- categories
- measurements
- group Id
- OG000
- value
- 5
- group Id
- OG001
- value
- 3
- title
- Partial Response (PR)
- denoms
- counts
- group Id
- OG000
- value
- 91
- group Id
- OG001
- value
- 15
- units
- Participants
- description
- Overall Objective Response will be assessed prior to dose-intensive therapy and at the completion of therapy. Complete disappearance of all clinical, radiographic and biochemical (normal AFP and HCG) evidence of disease for a minimum of 4 weeks (CR to chemotherapy). Patients must be free of disease for a minimum of 4 weeks. Partial Response: Complete disappearance of all biochemical evidence of disease in patients without a surgical procedure for a residual radiographic mass. Patients must demonstrate no biochemical recurrence or progression of radiographic masses for a minimum of four weeks (PR to chemotherapy}
- groups
- description
- Group A: Prior Treatment Limited to \<= 6 Cycles of Cisplatin
- id
- OG000
- title
- Group A
- description
- Group B: Prior Treatment Limited to \> 6 Cycles of Cisplatin
- id
- OG001
- title
- Group B
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 2 years
- title
- Overall Objective Response
- type
- PRIMARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice